Biodexa Pharmaceuticals Plc

Informe acción AIM:BDRX

Capitalización de mercado: UK£3.5m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Biodexa Pharmaceuticals Dirección

Dirección controles de criterios 4/4

Información clave

Stephen Stamp

Chief Executive Officer (CEO)

UK£237.9k

Compensación total

Porcentaje del salario del CEO99.4%
Permanencia del CEO3.6yrs
Participación del CEO0.003%
Permanencia media de la dirección2.3yrs
Promedio de permanencia en la Junta Directiva6yrs

Actualizaciones recientes de la dirección

Midatech Pharma plc (LON:MTPH) Insiders Have Been Selling

Feb 24
Midatech Pharma plc (LON:MTPH) Insiders Have Been Selling

Recent updates

Here's Why Midatech Pharma (LON:MTPH) Must Use Its Cash Wisely

May 17
Here's Why Midatech Pharma (LON:MTPH) Must Use Its Cash Wisely

Midatech Pharma plc (LON:MTPH) Insiders Have Been Selling

Feb 24
Midatech Pharma plc (LON:MTPH) Insiders Have Been Selling

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Stephen Stamp en comparación con los beneficios de Biodexa Pharmaceuticals?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2022n/an/a

-UK£5m

Mar 31 2022n/an/a

-UK£5m

Dec 31 2021UK£329kUK£187k

-UK£5m

Sep 30 2021n/an/a

-UK£7m

Jun 30 2021n/an/a

-UK£8m

Mar 31 2021n/an/a

-UK£15m

Dec 31 2020UK£193kUK£175k

-UK£22m

Jun 30 2020n/an/a

-UK£22m

Mar 31 2020n/an/a

-UK£16m

Dec 31 2019UK£207kUK£50k

-UK£9m

Compensación vs. Mercado: Stephen's total compensation ($USD296.50K) is about average for companies of similar size in the UK market ($USD349.05K).

Compensación vs. Ingresos: Stephen's compensation has been consistent with company performance over the past year.

CEO

Stephen Stamp (60 yo)

3.6yrs

Permanencia

UK£237,897

Compensación

Mr. Stephen A. Stamp serves as Chief Financial Officer and Director of Biodexa Pharmaceuticals Plc (formerly known as Midatech Pharma plc) since September 9, 2019. He serves as Chief Executive Officer at B...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Stephen Stamp
CEO, CFO3.6yrsUK£237.90k0.0026%
£ 93.7
Dmitry Zamoryakhin
Chief Scientific Officer1.8yrsUK£236.68ksin datos
Daniel Palmer
Vice President of Technology2.3yrssin datossin datos
Vincent Holmes
VP & Head of Clinical Operationsless than a yearsin datossin datos
David Benharris
President of Midatech Pharma US Inc7.3yrssin datossin datos
Fiona Sharp
Group Financial Controllerno datasin datossin datos

2.3yrs

Permanencia media

57yo

Promedio de edad

Equipo directivo experimentado: BDRX's management team is considered experienced (2.3 years average tenure).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Stephen Stamp
CEO, CFO3.6yrsUK£237.90k0.0026%
£ 93.7
Simon Turton
Senior Independent Non-Executive Director8.3yrsUK£31.54k0.0029%
£ 103.6
Stephen Parker
Non-Executive Chairmanless than a yearUK£43.84ksin datos
Daniel McCurdy
Member of Scientific Advisory Boardno datasin datossin datos
Sijmen de Vries
Independent Non-Executive Director18.5yrsUK£31.54k0.0012%
£ 44.0
Michael Natan
Member of Scientific Advisory Boardno datasin datossin datos
Francesco Stellaci
Chairman of Scientific Advisory Boardno datasin datossin datos
David Male
Member of Scientific Advisory Boardno datasin datossin datos
Lorraine O'Driscoll
Member of Scientific Advisory Boardno datasin datossin datos
Soledad Penades
Member of Scientific Advisory Boardno datasin datossin datos
Jean-Christophe Roux
Member of Scientific Advisory Boardno datasin datossin datos
Silke Krol
Member of Scientific Advisory Boardno datasin datossin datos

6.0yrs

Permanencia media

63yo

Promedio de edad

Junta con experiencia: BDRX's board of directors are considered experienced (6 years average tenure).